FTSE 100 stocks I’d buy after the US election results

FTSE 100’s sideways movement is underwhelming but not unsurprising as the US election results remain uncertain. However, there are some great individual stocks to buy now. 

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

There’s no clear winner in the US elections so far. Joe Biden is in the lead, but a win for the Democrats isn’t guaranteed. Unsurprisingly, stock markets are underwhelmed. The FTSE 100 index, for instance, has risen less than 1% so far today. I think the point to note here is that uncertain politics leads to uncertain markets. This has been amply clear to FTSE 100 investors since the Brexit vote. The point is underlined yet again now.

How I’d invest now

For me, this means that index investing is a no-go. I reckon the FTSE 100 won’t go anywhere in the days and months to come. I’d rather buy FTSE 100 stocks that are immune to political confusion or a weak economy. Clearly, this seems to be a consensus among the investing community today. Three of the top five FTSE 100 gainers today are healthcare provider AstraZeneca, pharmaceuticals company Hikma Pharmaceuticals, and e-grocer Ocado

FTSE 100 gainers

AstraZeneca has gained increased investor attention this year, since it began developing a Covid-19 vaccine. But even before that, it was a high-performing stock. Ideally, I’d wait for a dip before loading up on it, because its price has run up quite a bit. Similarly, Hikma Pharmaceuticals has signed an agreement with the US-based Gilead Sciences to manufacture its Covid-19 drug, Remdesivir. Compared to AstraZeneca, Hikma is affordable with an earnings ratio of less than 13 times, making it a good healthcare stock to buy.

Ocado’s share price increase to vertigo-inducing heights this year needs no introduction. As the convenience and safety of ordering supplies in catapulted demand for the online supermarket’s services to news highs, its share price followed suit. As the UK swings back into lockdown, Ocado will clearly continue to perform. Like AstraZeneca, its price may feel uncomfortably high too, but I don’t see it coming off meaningfully any time soon. Considering that there are no real FTSE 100 alternatives to the stock, I think now is a good time as any other to buy it. 

Indirect FTSE 100 beneficiaries

Apart from Ocado, online retailers in general have outperformed in 2020. Amazon is the most prominent example of this trend, but it’s not a UK-listed company. There are, however, FTSE 100 companies that have benefited from the online shopping trend. Consider paper packaging provider Smurfit Kappa. It’s also one of the biggest gainers today, following its trading update. It reported better than expected performance. 

There’s of course a possibility that as the recession makes a comeback, consumer spending will weaken enough to impact e-commerce sales. This, in turn, will impact the likes of Smurfit Kappa. However, if and how much the effect will be remains to be seen. I think this is another FTSE 100 stock to buy today. Alternatively, I’d consider its FTSE 100 peer DS Smith. Irrespective of the outcome of the US elections or any other political (non) triggers, I reckon these stocks will continue to be good buys. 

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Manika Premsingh owns shares of AstraZeneca and Ocado Group. The Motley Fool UK owns shares of and has recommended Amazon and Gilead Sciences. The Motley Fool UK has recommended DS Smith and Hikma Pharmaceuticals and recommends the following options: short January 2022 $1940 calls on Amazon and long January 2022 $1920 calls on Amazon. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Can someone invest like Warren Buffett with a spare £500?

Christopher Ruane explains why an investor without the resources of billionaire Warren Buffett could still learn from his stock market…

Read more »

Investing Articles

Can these 2 incredible FTSE 250 dividend stocks fly even higher in 2026?

Mark Hartley examines the potential in two FTSE 250 shares that have had an excellent year and considers what 2026…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Is 45 too late to start investing?

Investing at different life stages can come with its own challenges -- and rewards. Our writer considers why a 45-year-old…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

UK shares look cheap — but the market might be about to take notice

UK shares have traded at a persistent discount to their US counterparts. This can create huge opportunities, but investors need…

Read more »

Investing Articles

This FTSE 100 growth machine is showing positive signs for a 2026 recovery

FTSE 100 distributor Bunzl is already the second-largest holding in Stephen Wright’s Stocks and Shares ISA. What should his next…

Read more »

Investing Articles

I asked ChatGPT for the best FTSE 100 stocks to buy for passive income in 2026 and it said…

Paul Summers wanted to learn which dividend stocks an AI bot thinks might be worth buying for 2026. Its response…

Read more »

ISA Individual Savings Account
Investing Articles

Stop missing out! A Stocks and Shares ISA could help you retire early

Investors who don't use a Stocks and Shares ISA get all the risks that come with investing but with less…

Read more »

Investing Articles

Will Greggs shares crash again in 2026?

After a horrible 2025, Paul Summers takes a look at whether Greggs shares could sink even further in price next…

Read more »